Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1988 Mar;41(3):300–303. doi: 10.1136/jcp.41.3.300

Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis.

S Toikkanen 1, E Eerola 1, T O Ekfors 1
PMCID: PMC1141428  PMID: 2834422

Abstract

The DNA stemline of 45 mucinous breast carcinomas was determined by flow cytometry using paraffin embedded archival tissue sections. The material consisted of 26 pure mucinous and 19 mixed mucinous carcinomas. The patients were followed up for at least 15 years or until death. Nearly all pure mucinous carcinomas had a normal DNA stemline (25 of 26) with only one aneuploid tumour. Mixed mucinous carcinomas had a DNA content resembling that of common ductal carcinoma with 11 aneuploid tumours. Aneuploid tumours tended to be of higher grade and stage than diploid tumours. The survival of patients with pure mucinous carcinoma was better than that of patients with mixed mucinous carcinoma. Mucinous carcinoma should be classified as such only if it is a pure mucinous carcinoma.

Full text

PDF
300

Images in this article

301Fig 1
on p.301
301Fig 2
on p.301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLACK M. M., SPEER F. D. Nuclear structure in cancer tissues. Surg Gynecol Obstet. 1957 Jul;105(1):97–102. [PubMed] [Google Scholar]
  2. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clayton F. Pure mucinous carcinomas of breast: morphologic features and prognostic correlates. Hum Pathol. 1986 Jan;17(1):34–38. doi: 10.1016/s0046-8177(86)80152-6. [DOI] [PubMed] [Google Scholar]
  4. Cornelisse C. J., van de Velde C. J., Caspers R. J., Moolenaar A. J., Hermans J. DNA ploidy and survival in breast cancer patients. Cytometry. 1987 Mar;8(2):225–234. doi: 10.1002/cyto.990080217. [DOI] [PubMed] [Google Scholar]
  5. Crissman H. A., Steinkamp J. A. Rapid, simultaneous measurement of DNA, protein, and cell volume in single cells from large mammalian cell populations. J Cell Biol. 1973 Dec;59(3):766–771. doi: 10.1083/jcb.59.3.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Erhardt K., Auer G., Folin A., Silfverswärd C., Skoog L. Comparison between histologic type, estrogen receptor, and nuclear DNA content in mammary carcinoma. Am J Clin Oncol. 1986 Feb;9(1):83–89. doi: 10.1097/00000421-198602000-00019. [DOI] [PubMed] [Google Scholar]
  7. Hedley D. W., Friedlander M. L., Taylor I. W., Rugg C. A., Musgrove E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983 Nov;31(11):1333–1335. doi: 10.1177/31.11.6619538. [DOI] [PubMed] [Google Scholar]
  8. Hedley D. W., Rugg C. A., Ng A. B., Taylor I. W. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. Cancer Res. 1984 Nov;44(11):5395–5398. [PubMed] [Google Scholar]
  9. Horsfall D. J., Tilley W. D., Orell S. R., Marshall V. R., Cant E. L. Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer. Br J Cancer. 1986 Jan;53(1):23–28. doi: 10.1038/bjc.1986.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kute T. E., Muss H. B., Hopkins M., Marshall R., Case D., Kammire L. Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer. Breast Cancer Res Treat. 1985;6(2):113–121. doi: 10.1007/BF02235742. [DOI] [PubMed] [Google Scholar]
  11. Lee Y. T. Surgical treatment of carcinoma of the breast: III. Pathological finding and probability of relapse. J Surg Oncol. 1984 Feb;25(2):109–115. doi: 10.1002/jso.2930250212. [DOI] [PubMed] [Google Scholar]
  12. McDivitt R. W., Stone K. R., Craig R. B., Palmer J. O., Meyer J. S., Bauer W. C. A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers. Cancer. 1986 Jan 15;57(2):269–276. doi: 10.1002/1097-0142(19860115)57:2<269::aid-cncr2820570214>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  13. NORRIS H. J., TAYLOR H. B. PROGNOSIS OF MUCINOUS (GELATINOUS) CARCINOMA OF THE BREAST. Cancer. 1965 Jul;18:879–885. doi: 10.1002/1097-0142(196507)18:7<879::aid-cncr2820180716>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  14. Olszewski W., Darzynkiewicz Z., Rosen P. P., Schwartz M. K., Melamed M. R. Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor. Cancer. 1981 Aug 15;48(4):980–984. doi: 10.1002/1097-0142(19810815)48:4<980::aid-cncr2820480421>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  15. Owainati A. A., Robins R. A., Hinton C., Ellis I. O., Dowle C. S., Ferry B., Elston C. W., Blamey R. W., Baldwin R. W. Tumour aneuploidy, prognostic parameters and survival in primary breast cancer. Br J Cancer. 1987 Apr;55(4):449–454. doi: 10.1038/bjc.1987.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rasmussen B. B., Rose C., Christensen I. B. Prognostic factors in primary mucinous breast carcinoma. Am J Clin Pathol. 1987 Feb;87(2):155–160. doi: 10.1093/ajcp/87.2.155. [DOI] [PubMed] [Google Scholar]
  17. Silverberg S. G., Kay S., Chitale A. R., Levitt S. H. Colloid carcinoma of the breast. Am J Clin Pathol. 1971 Mar;55(3):355–363. doi: 10.1093/ajcp/55.3.355. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES